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Edited by Irmgard SinningDedicated to the memory of Laurence Ce´zanne who initiated this workAbstract Previous single-molecule studies have shown a long-
term diﬀusion superimposed to a short-term conﬁnement of the
human mu opioid (hMOP) receptors at the surface of heterolo-
gous cells. However, additional ensemble average measurements
are required to reach a complete understanding of the undergoing
process. Here, we analyse, by ﬂuorescence recovery after photo-
bleaching measurements, the lateral diﬀusion of fully functional
T7-EGFP-hMOP receptors in neuroblastoma SH-SY5Y cells
naturally expressing a low level of the wild-type receptor. Exper-
iments carried out at variable observation radii demonstrate the
restriction of the receptors diﬀusion to sub-micrometer sized
domains. Furthermore, consistently with the long-term single-
molecule data, the domains are found permeable.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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photobleaching1. Introduction
The signalling mechanism mediated by G-protein-coupled
receptors proceeds through transient and sequential molecular
interactions. The central step of the process takes place at the
membrane and involves the interaction between the receptor,
the heterotrimeric G-protein and the eﬀector. By contrast to
the long time prevailing collision-coupling model, the emerging
view is that of a compartmentalization (even a pre-coupling) of
the partners suggested to account for the rapidity and speciﬁc-
ity of signalling [1]. To date, experimental analyses of the diﬀu-
sion dedicated to the examination of the dynamic organization
of the receptors are not abundant. However, data exist that
have been obtained by ensemble average ﬂuorescence based
methods but also by single-molecule methods. Note that
although less directly than single-molecule tracking techniques,
ﬂuorescence recovery after photobleaching (FRAP) and ﬂuo-
rescence correlation spectroscopy (FCS) allow both for theAbbreviations: hMOP, human mu opioid; GPCR, G-protein-coupled
receptor; DAMGO, [D-Ala2 N-Me-Phe4Gly-ol5]enkephalin; CTAP,
D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2; DPN, diprenorphine;
cAMP, cyclic adenosin monophosphate
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doi:10.1016/j.febslet.2006.08.056characterization of domains when used at variable beam waist
for FCS [2] or variable observation area radius for vrFRAP [3].
Interestingly, all existing studies performed, making use of one
of these tools, revealed a conﬁnement of the receptors within
submicrometric domains. A vrFRAP analysis of the NK2
receptor diﬀusion showed that 30% of the receptors were re-
stricted in compartments of about 300 nm size [4] at the surface
of HEK cells. Single-molecule ﬂuorescence tracking of NK1
and odorant receptors in the plasma membrane of HEK cells
revealed a diﬀusion conﬁned to domains of size ranging from
200 nm to 1 lm [5,6]. The membrane dynamic of the human
mu opioid (hMOP) receptor has been recently investigated in
ﬁbroblast cells using single particle tracking (SPT) at variable
temporal resolutions [7,8]. Experiments pursued in diﬀerent
groups diﬀered in the interpretation of the observed long term
random diﬀusion but showed consistently a diﬀusion conﬁned
at short term. The associated domain size was found comprised
between 200 and 700 nm depending on the acquisition rate and
the presupposed geometry of the domains in the equation used
to determine the domain size from the ﬁt of the mean square
displacement as a function of time [7–9]. Although necessary
for their total validation, these observations have not yet been
comforted by ensemble measurements.
The signalling process is far more complicated than de-
scribed in the simpliﬁed scheme above and involves, in addi-
tion to the encounter of the receptor, the protein G and the
eﬀector, interactions with a number of cytosolic proteins which
could inﬂuence the organization of the receptor [1,10,11]. Thus
it can be anticipated that, in order to be fully relevant, the
analysis of the functional membrane dynamics of G-protein-
coupled receptor (GPCR) should be performed in native cells.
The hMOP receptor, involved in pain phenomena, is predom-
inantly found in the nervous central system [12]. We chose to
explore the behavior of the receptor in neuronal cells. How-
ever, to date, due to the lack of high aﬃnity speciﬁc antibodies,
labelling of the native receptor for diﬀusion experiments can-
not be envisaged. Thus, the SH-SY5Y neuroblastoma cell line,
which expresses endogenously the hMOP receptor, was stably
transfected by the cDNA construct encoding for the T7-
EGFP-hMOP receptor. After having checked for the full
functionality of the chimeric receptor, we performed vrFRAP
measurements to analyse its diﬀusional behaviour at the sur-
face of the neuroblastoma cells. Consistently with the previous
single-molecule analysis on heterologous cells, we found the
diﬀusion of the receptor to be restricted to domains.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of the pRC/CMV/SP-T7-EGFP-
hMOP vector used in this work. SP: Signal peptide of the nicotinic-
acetylcholine receptor a7 subunit; T7: T7-Tag; EGFP: Enhanced green
ﬂuorescent protein; hMOP: human mu opioid.
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2.1. Constructions
In construct A, double-stranded synthetic oligonucleotides encoding
for the corresponding regions of the signal peptide of nicotinic-acetyl-
choline receptor a7 subunit (SP/a7AChR) followed by the T7 epitope
(MASMTGGQQMG) was inserted into the HindIII/SacI site of
bluescript SK+ plasmid (Stratagene). At the 3 0 end of T7 epitope
gene, SmaI–NheI–PstI–XbaI restriction sites were introduced. In con-
struct B, a recombinant EGFP lacking in ATG and stop codons
was ampliﬁed from PEGFP-N1 (Clontech) by PCR using 5 0-
CACGTGGCTAGCGTGAGCAAGGGCGAGCTG-3 0 sense and 5 0-
CACGTGCTGCAGCTTGTACAGCTCGTCCATGCC-30 antisense
primers. These created the PmlI, NheI sites (underlined) at the 5 0 end
of sense primer andPmlI,PstI sites (underlined) at the 5 0 endof antisense
primer. The ampliﬁed fragment (0.7 Kb) digested by PmlI was inserted
intoEcoRV site of bluescript SK+ plasmid. In construct C, the ATG co-
dons in theHindIII toEco47III fragment of hMOPcDNA (clonedHind-
III–XbaI in bluescript SK+) was suppressed by replacing this fragment
by double-stranded synthetic oligonucleotides without ATG codons.
At the 5 0 endof hMOPgenePstI,SnaBI restriction siteswere introduced.
Finally, the modiﬁed EGFP fragment (construct B) was excised by a
NheI/PstI digestion and introduced in construct A to give bluescript
SK+SP/a7AChR-T7-EGFPplasmid inwhich constructC (PstI toXBaI
fragment of hMOP) was inserted into the PstI/XbaI sites. After control
of the resulting construct SP/a7AChR-T7-EGFP-hMOP by restriction
enzyme analysis and sequencing, it was subcloned in eucaryotic expres-
sion vector pRC/CMV(Invitrogen) at HindIII/XbaI restriction sites.
2.2. Cell culture and transfection
Cells were grown in DMEM supplemented with 10% foetal calf
serum, glutamine, and antibiotic (0.05 mg/ml gentamicin) at 37 C in
5% CO2 atmosphere. Cells (4 · 106) were transfected with plasmid
pRC/CMV-SP/a7AChR-T7-EGFP-hMOR (15 lg) using Lipofect-
amine 200 (Invitrogen) for SH-SY5Y neuroblastoma cells, or CaCl2
for transiently transfected COS-M6 cells. Stable SH-SY5Y transfected
cell line was obtained and maintained by addition of 0.4 mg/ml neomy-
cin (G418, Gibco) in the culture medium.
2.3. Western blot analysis
Aliquots of 10 lg were analysed by SDS–PAGE on 12% polyacryl-
amide gel. After electrotransfer of the proteins to a nitrocellulose mem-
brane [13], it was blocked in TBST, 5% non fat dried milk, 0.2% Tween
20 for 1 h and then immunostained with 1:5000 anti-T7 HRP antibody
(Novagen) for 1 h at room temperature. Membrane was washed ﬁve
times with TBST prior to detection with ECL method (Perkin Elmer).
2.4. Membranes preparation
Conﬂuent cells were harvested by incubation at 37 C for 20 min in
PBS (1.5 mM EDTA). A cell pellet was prepared by centrifugation
(200 · g, 10 min). After resuspension in TE (Tris 50 mM, 1 mM EDTA
and pH 7.4) with protease inhibitor (Complete Mini, Roche), it was
disrupted by nitrogen cavitation and centrifuged (1500 · g, 10 min).
The supernatant was further centrifuged (100000 · g, 40 min) and
the resulting membrane pellet resuspended in TE.
2.5. Binding assays
Experiments were performed on membrane aliquots (20–200 lg) as
described previously [14] using radiolabelled ligands [3H]DAMGO or
[3H]DPN (0.1–4 nM) for saturation assays, and morphine or D-Phe-
Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(CTAP) (4 nM–0.2 lM) for
competition against [3H]DPN (1 nM). Bound radioactivity was mea-
sured in a Liquid Scintillation Analyser (Tri-Card 2100TR, Packard).
Dissociation constant (Kd) and receptor densities (Bmax) were calcu-
lated by Scatchard’s analyses [15]. Inhibition constants (Ki) were
calculated from inhibition assays of [3H]DPN binding. Data were ana-
lysed using Prism software (GraphPad Software).
2.6. cAMP accumulation assays
Cyclic adenosin monophosphate (cAMP) level was determined after
cell stimulation by 10 lM forskolin in the presence or not of [D-Ala2
N-Me-Phe4Gly-ol5]enkephalin (DAMGO) or morphine at concentra-
tions ranging from 1 to 105 lM as described by Capeyrou et al. [16].2.7. Membrane protein, lipid and cholesterol content measurements
Membrane protein concentrations were determined by the method
of Lowry et al. [17] using bovine serum albumin as standard. Lipid
extracts were prepared following the Bligh–Dyer method [18]. Choles-
terol content was measured using the method of Zlatkis [19]. Phospho-
lipids were quantiﬁed using a phosphorus assay [20].
2.8. FRAP measurements
Two days before the experiment, cells were plated on coverslips.
After a careful rinsing of the cells with PBS, coverslips were placed
in a home made stage and constituted one of the faces of a microscope
chamber of 30 lm depth. FRAP measurements were performed at
20 ± 1 C (additional experiments were made at 37 C) in uniform disk
illumination conditions using an epiﬂuorescence microscope based de-
vice. The radius of the observation area was varied between 1.4 and
3.45 lm, the bleaching time was set between 20 and 50 ms and recov-
eries were followed during 30 s. Three independent campaigns of
experiments were performed proceeding each to the acquisition of 30
ﬂuorescence recoveries for each observation radius on diﬀerent cells.
The resulting ﬂuorescence recovery curves of one campaign measure-
ments are cumulated for each radius and then ﬁtted using the expected
theoretical equation for a single population to determine the corre-
sponding apparent diﬀusion coeﬃcient and mobile fraction [21].3. Results and discussion
3.1. Pharmacological characterisation of T7-GFP-hMOP
receptor in SH-SY5Y
In addition to the EGFP required for FRAP measurements
and a T7 tag allowing for recognition by high aﬃnity speciﬁc
antibodies, the cleavable signal peptide of the nicotinic
a7AChR was also fused at the N terminus of hMOP receptor
to address properly the chimeric receptor at the cell surface
(Fig. 1, [22]). To avoid bias or perturbations to the membrane
organization that could originate from transient transfections,
a SH-SY5Y stable cell line expressing T7-EGFP-hMOP recep-
tor was established and fully characterized.
3.1.1. Transfection and membrane expression. To guaran-
tee an homogeneous level of expression of the receptor among
the cells after transfection, a monoclonal cell line was selected.
This was conﬁrmed with a unimodal distribution showed by
ﬂux cytometry analysis (data not shown). The membrane
expression of the transfected receptor was checked by ﬂuores-
cence confocal microscopy. Cells exhibited homogeneously
ﬂuorescent plasma membranes and no aggregates were visible
in the cytoplasm (Fig. 3A). Furthermore, Western blot analysis
using an anti-T7 antibody showed a single band at the molec-
ular weight of glycosylated receptor suggesting that no trun-
cated forms of the fusion protein were generated upon
targeting to the plasma membrane (Fig. 2).
3.1.2. Binding and adenylyl cyclase inhibition. Binding of
agonist and antagonist ligands to cell membranes was mea-
sured either directly using radiolabelled ligands or by competi-
Fig. 2. Western blot analysis of WT SH-SY5Y cells and SH-SY5Y
expressing T7-EGFP-hMOP. Using monoclonal anti-T7 HRP anti-
body, a band is revealed at the expected molecular weight (93 kDa) in
transfected cells, whereas no band is found in wild type cells.
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wild-type and transfected SH-SY5Y cells.
Within the concentration range explored, speciﬁc binding of
[3H]DPN and [3H]DAMGO were saturable. DPN binding
measurements revealed a T7-EGFP-hMOP density (Bmax) of
2.9 pmol/mg of protein in the transfected SH-SY5Y mem-
brane, ten fold larger than that of the endogenous receptor
in WT SH-SY5Y cells. The measured Kd for DPN and
DAMGO and Ki for CTAP and morphine in transfected cells
are in agreement with those obtained for the endogenous
hMOP receptor in WT SH-SY5Y cells (Table 1 and [23])
and for the same construct transiently expressed in COS-M6
cells lacking in the endogenous hMOP receptor (Table 1).
The chimeric receptor functionality was further investigated
by evaluating the decrease of cellular cAMP level following
activation by an agonist after stimulation of the adenylylTable 1
Pharmacological properties of endogenous hMOP in SH-SY5Y WT and T7
Ligands Pharmacological parameters hMOP SH-SY5Y
DAMGO Kd (nM) 2.69 ± 1.67
Bmax (pmol/mg prot) 0.02 ± 0.01
DPN Kd (nM) 0.73 ± 0.14
Bmax (pmol/mg prot) 0.23 ± 0.02
Morphine Ki (nM) nd
CTAP Ki (nM) nd
Fig. 3. Confocal images showing the localisation of T7-EGFP-hMOP in t
presence of ligands. Plasma membrane localisation of ﬂuorescent receptors w
(CTAP, 1 lM, 30 min) does not change the ﬂuorescence pattern (B) whereas
internalisation (C). Scale bar is 20 lm.cyclase by forskolin. Both DAMGO and morphine inhibited
cAMP production in a concentration-dependent manner. In
transfected SH-SY5Y, a maximum decrease of 95% of cAMP
level was observed while, in concordance with literature data
[23], it was limited to 30% in WT cells presumably due to
the low expression level of the endogenous receptor. The
EC50 in transfected cells were found to be equal to 0.40 nM
for DAMGO and of 2.2 nM for morphine comparable to the
values obtained in WT cells (data not shown).
3.1.3. Receptor internalization. As a further investigation
of cellular response consecutive to ligand binding we qualita-
tively examined the localisation of the T7-EGFP-hMOP recep-
tor after exposure to saturating concentrations of antagonist
and agonist. The latter generally induces the internalization
of GPCRs [1,24].
Fluorescence images of the cells captured after 30 min incu-
bation with 1 lM ligand solutions at room temperature are
shown in Fig. 3. After exposure to an antagonist, CTAP or
DPN, cells exhibited a ﬂuorescence restricted to the plasma
membrane (Fig. 3B) with no detectable change from the basal
state (Fig. 3A). On the contrary, the peptide agonist DAMGO
induced T7-EGFP-hMOP receptor internalization detected as
the strong decrease of the labelling of the plasma membrane
together with the presence of numerous ﬂuorescent intracellu-
lar vesicles (Fig. 3C). As expected, receptor internalization was
accelerated at 37 C for DAMGO and took place within only
ﬁve minutes, a kinetics similar to that observed for endogenous
wild-type receptors in neurons [25]. Morphine led also to inter-
nalization of the receptor but much less rapidly, consistently
with previous reports [26] (data not shown).
3.1.4. Membrane composition. The determined relative
protein, cholesterol, lipid proportions and lipidic composition
of cell membranes were found comparable for WT and trans-
fected SH-SY5Y showing a probable absence of eﬀect of the
transfection on the membrane environment of the receptor.-EGFP-hMOP in SH-SY5Y and COS-M6 cells
T7-EGFP-hMOP SH-SY5Y T7-EGFP-hMOP COS-M6
1.60 ± 0.21 1.30 ± 0.60
0.94 ± 0.14 nd
0.33 ± 0.10 0.34 ± 0.16
2.90 ± 0.23 nd
27 ± 13 18 ± 2
1.1 ± 0.5 0.9 ± 0.2
ransfected SH-SY5Y cell line at room temperature, in absence or in
ithout activation is shown in panel (A). Incubation with an antagonist
incubation with an agonist (DAMGO, 1 lM, 30 min) induced receptor
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Fig. 4. FRAP experiment: normalized ﬂuorescence intensity as a
function of time. The recovery data (grey dots) is ﬁtted (black curve)
by the expected theoretical equation for a single population (see text).
Here the observation area radius is equal to 2.95 lm, the ﬁt leads to
M = 74 ± 1% and Dm = 1.8 ± 0.1 lm
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Fig. 5. Plot of the mobile fraction M versus the inverse of the radius
of the observed area obtained in one set of FRAP experiments.
Measurements were performed at 20 C (black diamonds) and 37 C
(grey squares). The slope of the linear ﬁt gives the domain radius (see
text). Insert shows the corresponding variations of Dm (ﬁlled symbols)
and Do (calculated from Dm according to Eq. (2), open symbols) versus
the opposite of the radius of the observed area. Each symbol represents
a set of about 30 experiments, carried out during the same campaign of
measurement, error bars (95% conﬁdence level) are within symbols.
5230 A. Saulie`re et al. / FEBS Letters 580 (2006) 5227–5231As found previously [27], the major fatty acids were C18:0,
C16:0 and unsatured C18, phosphatidylcholine (PC) was the
main polar head (40 ± 4%) while sphingomyelin (SM), phos-
phatidylethanolamine (PE), phosphatidylinositol (PI) and
phosphatidylserine (PS) were found in similar proportions
(12–15%). Cholesterol content represented 31 ± 4% mol/mol
of the phospholipids and the phospholipid to protein ratio
was found equal to 232 ± 45 lmol/g.
In conclusion, we showed that T7-EGFP-hMOP receptor
stably expressed in SH-SY5Y cells is properly targeted at the
plasma membrane. Moreover, this chimeric receptor exhibits
full ligand binding and adenylyl cyclase inhibition capacities
as compared to the endogenous receptor. The further dynamic
analysis of T7-EGFP-hMOP receptor in transfected SH-SY5Y
cells will thus report an accurate perception of the native recep-
tor behaviour in its natural environment.
3.2. Variable radius FRAP measurements
FRAP experiments carried out at variable radius of the illu-
minated area (vrFRAP) allow when domains exist to identify
their presence and determine their size r by the relation ex-
pected between the mobile fraction M, the observation radius
R and r:
M ¼ 0:63r=RþMp ð1Þ
where the constant mobile fraction Mp can originate from free
diﬀusion apart from disconnected domains or from apertures
in the frontiers of juxtaposed domains. In the simple case of
a membrane organized in connected (or juxtaposed but discon-
nected) domains, the diﬀusion coeﬃcient Do inside the do-
mains can be derivated from the measured apparent one Dm
using the equation [3].
Do ¼ 1=2Dmðr=RÞ2 ð2Þ
Prior to go through this thorough analysis of the data, we
ﬁrst checked for the eventual existence of two populations.
The computed recovery curves were systematically not better
described by the cumulative contribution of two populations
with diﬀerent diﬀusion coeﬃcients (Fig. 4). The three indepen-
dent campaigns of experiments performed at various R led to
three sets of coupled parameters: M = f(R) and Dm = f(R).
On M versus 1/R plots, all data points are found distributed
on a straight line of positive slope intercepting the y axis at a
non zero value (Fig. 5). This is in favor of a compartmentali-
zation of the receptors, at least partial or within partially leak-
ing domains. From the linear regression of the plot, we
deduced a domain radius equal to 700 ± 100 nm and a perma-
nent mobile fraction Mp of 55 ± 5%. According to Salome´
et al. [3], drastic eﬀects on the contribution to long distance dif-
fusion is expected for moderate leaking of the domains. Such a
value of Mp can be accounted for by a 7% aperture of the
perimeter of the domains. The measured diﬀusion coeﬃcients
Dm tended to increase with the observation radius R. The val-
ues of the measured diﬀusion coeﬃcients comprised between
0.8 and 1.4 lm2/s are abnormally large consistently with the
fact that conﬁned diﬀusion lead to apparent biased values of
the diﬀusion coeﬃcient. Using Eq. (2), the recalculated diﬀu-
sion coeﬃcient Do was found constant and close to
3 · 102 lm2/s as it can be expected for a protein diﬀusion
coeﬃcient in the plasma membrane [7,28] (Fig. 5). Recovering
a value of Do, lower than any measured Dm, independent of R,strongly suggests that the ensemble of the receptors are distrib-
uted within domains where they diﬀuse with Do with an escape
probability to a neighbouring domain leading to long range
diﬀusion. As shown in Fig. 5, experiments performed at
37 C led to results identical to those obtained at 20 C: the
domain size and diﬀusion coeﬃcient inside the domains are
unchanged. As a raise in temperature is expected to increase
the membrane ﬂuidity [29], this might reﬂect the occurrence
of additional interactions which slow down the diﬀusion while
maintaining the underlying dynamic organization of the recep-
tors.
Such a dynamic organization of the receptor is in contrast to
the one evidenced by vrFRAP for the NK2 receptors that were
found to be only partially conﬁned in sub-micrometer closed
A. Saulie`re et al. / FEBS Letters 580 (2006) 5227–5231 5231domains (35%) while the majority exhibited a long-range free
diﬀusion (65%) [4]. On the other hand, the permanent short-
term conﬁnement evidenced by vrFRAP is quite consistent
with the hMOP receptor single particle tracking existing data.
The diﬀusion coeﬃcients diﬀer by a factor of 4 accordingly to
the diﬀerence found between measurements performed by
FRAP and SPT on lipidic bilayers [30]. However, domain sizes
found by vrFRAP on the neuroblastoma cells tend to be signif-
icantly larger than those by SPT on ﬁbroblasts but this would
need further investigation to settle whether it originates from
the diﬀerences in the cell lines or in the techniques. More
importantly, our results raise the question of the underlying
mechanism for the passage between domains. It could be
due, depending on the conﬁnement origin, either to the escape
from a trapping potential to a neighboring one or to a perme-
ability of rigid fences delineating the domains [31]. Now, fur-
ther experiments are needed on ligand bounded receptors to
address this issue and give insights into the functional role
for this dynamic conﬁnement of the receptors.Acknowledgements: This work and G.G. was supported by CNRS and
MENESR joint DRAB program. A.S. is the recipient of a postgradu-
ate fellowship from MENESR.References
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